1 |
Vitorino M, Baptista de Almeida S, Alpuim Costa D, Faria A, Calhau C, Azambuja Braga S. Human Microbiota and Immunotherapy in Breast Cancer - A Review of Recent Developments. Front Oncol 2022;11:815772. [DOI: 10.3389/fonc.2021.815772] [Reference Citation Analysis]
|
2 |
Peruhova M, Peshevska-Sekulovska M, Velikova T. Interactions between human microbiome, liver diseases, and immunosuppression after liver transplant. World J Immunol 2021; 11(2): 11-16 [DOI: 10.5411/wji.v11.i2.11] [Cited by in CrossRef: 1] [Article Influence: 1.0] [Reference Citation Analysis]
|
3 |
Li Y, Wang S, Lin M, Hou C, Li C, Li G. Analysis of interactions of immune checkpoint inhibitors with antibiotics in cancer therapy. Front Med 2022. [PMID: 35648368 DOI: 10.1007/s11684-022-0927-0] [Reference Citation Analysis]
|
4 |
Wu M, Bai J, Ma C, Wei J, Du X. The Role of Gut Microbiota in Tumor Immunotherapy. J Immunol Res 2021;2021:5061570. [PMID: 34485534 DOI: 10.1155/2021/5061570] [Reference Citation Analysis]
|
5 |
Grochowska M, Perlejewski K, Laskus T, Radkowski M. The Role of Gut Microbiota in Gastrointestinal Tract Cancers. Arch Immunol Ther Exp (Warsz) 2022;70:7. [PMID: 35112169 DOI: 10.1007/s00005-021-00641-6] [Reference Citation Analysis]
|